Clock Ticking Rivian Stock: Is Now the Time to Buy?
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
Learn why financial indices are useful benchmarks, guide portfolio decisions, and help you compare performance across assets.
25,072 articlesRivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
A private market deal around a smartphone rewards model is near closing, riding momentum from Deloitte’s fastest-grow...
Gaotu's Q1 2026 earnings reveal clues about growth, profitability, and execution in a competitive online education ma...
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
A fresh NAHB study finds regulatory costs have raised the typical new-home price by about $131,734, representing 26.4...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
A blowout quarter sent AeroVironment stock soaring, but the bigger question for investors is whether the drone boom h...
Investors are placing massive bets on Eli Lilly’s GLP-1 drugs, but the push for a $1 trillion opportunity faces medic...
Could SpaceX expand from rockets to handheld devices? This article examines the idea of spacex planning make smartpho...
Many retirees fixate on social security everyone fears, but the real danger lies in a mix of health costs, market swi...
A blockchain analysis firm flags a pattern of Russia-linked crypto platforms routing large transfers to evade sanctio...
February delivered a sharp setback for AMZN as investors weighed another wave of capital spending against growth pros...